An exemestane derivative, oxymestane-d1, as a new multi-target steroidal aromatase inhibitor for estrogen receptor-positive (er+) breast cancer: effects on sensitive and resistant cell lines

HIGHLIGHTS

• who: Cristina Amaral and colleagues from the University of, Rua Jorge Viterbo, nu25e6, National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark have published the article: An Exemestane Derivative, Oxymestane-D1, as a New Multi-Target Steroidal Aromatase Inhibitor for Estrogen Receptor-Positive (ER+) Breast Cancer: Effects on Sensitive and Resistant Cell Lines, in the Journal: Molecules 2023, 789 of /2023/
• what: Following this line of research, in this work the authors investigated the anti-cancer properties and the multi-target potential of the compound 1u03b1,2u03b1-epoxy-6methylenandrost-4-ene-3,17-dione . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.